Elementzero Biolabs
Entrepreneur First '20Berlin, DE · Founded 2020 · 1 known investors
ElementZero Biolabs produces reagents that boost the amplification of DNA and RNA targets present at very low concentrations, reporting roughly 100 times greater sensitivity than standard approaches. The chemistry is intended for point-of-care and research settings, allowing genetic markers to be detected without specialized instruments or extended protocols.
Also known as Element Zero Biolabs · ElementZero Biolabs
Founders & leadership
Elementzero Biolabs was founded in 2020 by John Moura and Karol Rogowski.
Investors · 1
Company profile
researched Aug 2026Elementzero Biolabs is a Berlin, Germany-based biotechnology company working on reagent chemistry for nucleic acid amplification. Its products are intended to raise the sensitivity with which DNA and RNA targets present at very low concentrations can be amplified and detected, with the stated aim of enabling genetic markers to be identified without specialised instrumentation or long protocols.
None of the public source documents supplied for this profile concern Elementzero Biolabs. The retrieved documents cover an unrelated acquisition by Element Biosciences of Loop Genomics, a general directory listing of life-science company acquisitions, and a general commentary article about startups that shut down after being acquired; these are name twins or otherwise irrelevant and contribute no facts. As a result, no externally sourced funding rounds, metrics, events, customers, partnerships, or team details could be verified, and the profile rests entirely on internally held records.
Latest developments
No recent developments concerning Elementzero Biolabs appear in the supplied public sources; the most recent material fetched relates to unrelated companies.
▸Full profile — technology, go-to-market, risks & controversies
Technology
Reagent chemistry intended to boost amplification of low-concentration DNA and RNA targets. No public source document in this set describes the technology, so no further technical detail can be verified.
Go-to-market
Internal records indicate the chemistry is aimed at point-of-care and research settings, i.e. researchers and clinicians; no public source in this set corroborates or expands on the customer base.
Risks & controversies
No risks or controversies relating to Elementzero Biolabs are documented in the supplied sources. A general research risk is name confusion with similarly named genomics companies such as Element Biosciences, which is a distinct organisation.
Compiled by commissioned research from 3 cited public sources — announcements, filings, and press listed under research sources below.
▸Research sources · 3
primary sources listed
- Element Biosciences Closes Acquisition of Loop Genomics - BioSpacebiospace.com · web
3 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Elementzero Biolabs do?
- Berlin-based developer of reagents that increase the sensitivity of DNA and RNA amplification for point-of-care genetic testing.
- Who founded Elementzero Biolabs?
- Elementzero Biolabs was founded by John Moura, Karol Rogowski in 2020.
- Who are Elementzero Biolabs's investors?
- Elementzero Biolabs's investors include Entrepreneur First.
- Where is Elementzero Biolabs headquartered?
- Elementzero Biolabs is headquartered in Berlin, DE.